StreetInsider.com News Articles

Form 8-K SANGAMO THERAPEUTICS, For: Oct 14

Fri, 16 Oct 2026 06:00:00 -0400

si-local-file:///var/storage/secattach/20261016/27195080.html

Sangamo launches auction for pain program amid Chapter 11 proceedings

Tue, 13 Oct 2026 16:01:53 -0400

Sangamo Therapeutics, Inc. (OTCID Basic Market: SGMOQ) has initiated an auction process for its ST-503 program, a clinical-stage investigational treatment for chronic neuropathic pain caused by small fiber neuropathy (SFN). The auction is expected to conclude in the fourth quarter of 2026, according to a press release from the company.

ST-503 uses an adeno-associated virus vector to deliver an engineered zinc finger repressor designed to reduce expression of SCN9A, the gene encoding the Nav1.7 sodium channel involved in pain signaling. Seven sites have been activated in the Phase 1/2 STAND study evaluating the treatment's safety and efficacy. The U.S. Food and

Sangamo launches auction for pain program amid Chapter 11 proceedings

Tue, 13 Oct 2026 16:01:53 -0400

Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program

Tue, 13 Oct 2026 16:01:00 -0400

Auction process initiated for ST-503 program for chronic neuropathic pain, expected to be completed in fourth quarter of 2026

Previously announced asset sale transactions with PTC and Lilly have closed, generating $163.55 million in gross cash proceeds

RICHMOND, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (OTCID Basic Market: SGMOQ) today announced the new timeline for its continued sale process for the ST-503 program, a clinical-stage investigational epigenetic regulator for the treatment of intractable pain due to small fiber neuropathy (SFN).

Seven sites have been activated in the Phase

Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program

Tue, 13 Oct 2026 16:01:00 -0400

Auction process initiated for ST-503 program for chronic neuropathic pain, expected to be completed in fourth quarter of 2026

Previously announced asset sale transactions with PTC and Lilly have closed, generating $163.55 million in gross cash proceeds

Seven sites have been activated in the Phase

Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program

Tue, 13 Oct 2026 16:01:00 -0400

Auction process initiated for ST-503 program for chronic neuropathic pain, expected to be completed in fourth quarter of 2026

Previously announced asset sale transactions with PTC and Lilly have closed, generating $163.55 million in gross cash proceeds

Seven sites have been activated in the Phase

Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program

Tue, 13 Oct 2026 16:01:00 -0400

Auction process initiated for ST-503 program for chronic neuropathic pain, expected to be completed in fourth quarter of 2026

Previously announced asset sale transactions with PTC and Lilly have closed, generating $163.55 million in gross cash proceeds

Seven sites have been activated in the Phase

Form 25-NSE SANGAMO THERAPEUTICS, Filed by: Nasdaq Stock Market LLC

Wed, 07 Oct 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20261007/27157390.html

Form 8-K SANGAMO THERAPEUTICS, For: Sep 17

Mon, 21 Sep 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260921/27085306.html

Form 8-K SANGAMO THERAPEUTICS, For: Aug 25

Fri, 28 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260828/26997855.html

Form 8-K SANGAMO THERAPEUTICS, For: Aug 25

Fri, 28 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260828/26997855.html

Form NT 10-Q SANGAMO THERAPEUTICS, For: Jun 30

Mon, 17 Aug 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260817/26938863.html

Form NT 10-Q SANGAMO THERAPEUTICS, For: Jun 30

Mon, 17 Aug 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260817/26938863.html

Form SCHEDULE 13G/A SANGAMO THERAPEUTICS, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:26:00 -0400

si-local-file:///var/storage/secattach/20260814/26926400.html

Form SCHEDULE 13G/A SANGAMO THERAPEUTICS, Filed by: ARMISTICE CAPITAL, LLC

Fri, 14 Aug 2026 10:26:00 -0400

si-local-file:///var/storage/secattach/20260814/26926400.html

Form 8-K SANGAMO THERAPEUTICS, For: Aug 12

Thu, 13 Aug 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260813/26915700.html

Form 8-K SANGAMO THERAPEUTICS, For: Aug 12

Thu, 13 Aug 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260813/26915700.html

Form 8-K SANGAMO THERAPEUTICS, For: Aug 06

Wed, 12 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26912629.html

Form 8-K SANGAMO THERAPEUTICS, For: Aug 06

Wed, 12 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26912629.html

Form 8-K SANGAMO THERAPEUTICS, For: Jul 14

Mon, 20 Jul 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260720/26790202.html

Form 8-K SANGAMO THERAPEUTICS, For: Jul 14

Mon, 20 Jul 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260720/26790202.html

Form 8-K SANGAMO THERAPEUTICS, For: Jun 24

Wed, 01 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260701/26720478.html

Form 8-K SANGAMO THERAPEUTICS, For: Jun 24

Wed, 01 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260701/26720478.html

Form 8-K SANGAMO THERAPEUTICS, For: Jun 24

Wed, 01 Jul 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260701/26720478.html